UNCY earnings: a positive outcome, +11.7%

On March 31, 2023, Unicycive Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +11.7% in the window around the event. It had already run +246.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.